Idex Corporation · NYSE:IEX

Idex — Q4 2013 Earnings Presentation

11 slides from Idex's earnings presentation, Feb 4, 2014

  1. Slide 1: Fourth Quarter 2013 Earnings Release

    IDEX PROPRIETARY & CONFIDENTIAL 1 IDEX PROPRIETARY & CONFIDENTIAL Fourth Quarter 2013 Earnings Release January 30, 2014 IDEX PROPRIETARY & CONFIDENTIAL

  2. Slide 2: Agenda

    IDEX PROPRIETARY & CONFIDENTIAL 2 IDEX PROPRIETARY & CONFIDENTIAL Agenda • IDEX Outlook • 2013 Financial Performance • 2013 Segment Performance • Fluid & Metering • Health & Science • Fire & Safety / Diversified • 2014 Guidance Update • Q&A

  3. Slide 3: Replay Information

    IDEX PROPRIETARY & CONFIDENTIAL 3 IDEX PROPRIETARY & CONFIDENTIAL Replay Information • Dial toll–free: 855.859.2056 • International: 404.537.3406 • Conference ID: #30410743 • Log on to: www.idexcorp.com

  4. Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act

    IDEX PROPRIETARY & CONFIDENTIAL 4 IDEX PROPRIETARY & CONFIDENTIAL Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward-looking statements. Our actual performance may differ materially from that indicated or suggested by any suc

  5. Slide 5: IDEX 2013 Financial Performance

    IDEX PROPRIETARY & CONFIDENTIAL 5 IDEX PROPRIETARY & CONFIDENTIAL $0 $200 $400 Q4 Year $79 $295 $95 $379 2012 2013 15% 17% 19% 21% 23% Q4 Year 18.5% 18.4% 20.0% 19.5% 2012 2013 $0.25 $1.25 $2.25 $3.25 Q4 Year $0.82 $3.09 $0.69 $2.68 2012 2013 $0 $500 $1,000 $1,500 $2,000 Q4 Year $491 $1,954 $521 $2,

  6. Slide 6: Fluid & Metering

    IDEX PROPRIETARY & CONFIDENTIAL 6 IDEX PROPRIETARY & CONFIDENTIAL $0 $200 $400 $600 $800 $1,000 Q4 Year $209 $836 $209 $869 2012 2013 $0 $200 $400 $600 $800 $1,000 Q4 Year $212 $833 $222 $872 2012 2013 10% 15% 20% 25% 30% Q4 Year 21.0% 21.7% 24. % 24.2% 2012 2013 Fluid & Metering Orders Revenue Q4 R

  7. Slide 7: Health & Science

    IDEX PROPRIETARY & CONFIDENTIAL 7 IDEX PROPRIETARY & CONFIDENTIAL $0 $200 $400 $600 $800 $1,000 Q4 Year $170 $674 $190 $723 2012 2013 $0 $200 400 $600 $800 $1,000 Q4 Year $175 $695 $182 $715 2012 2013 10% 13% 15% 18% 20% Q4 Year 18.4% 17.6% 18.2% 19.1% 2012 2013 Health & Science Orders Revenue Organ

  8. Slide 8: Fire & Safety/Diversified

    IDEX PROPRIETARY & CONFIDENTIAL 8 IDEX PROPRIETARY & CONFIDENTIAL $0 $100 $200 $300 $400 $500 Q4 Year $107 $444 $125 $488 2012 2013 $0 $100 $200 $300 $400 $500 Q4 Year $109 $437 $118 $445 2012 2013 10% 15% 20% 25% 30% Q4 ear 24.2% 23.9% 24.3% 23.1% 2012 2013 Fire & Safety/Diversified Orders Revenue

  9. Slide 9: 2014 Guidance Detail

    IDEX PROPRIETARY & CONFIDENTIAL 9 IDEX PROPRIETARY & CONFIDENTIAL 2014 Guidance Detail Sales EPS (in M's) FY 2013 Actuals $2,024 $3.09 Organic growth ~ 60 - 100 ~ 0.20 - 0.30 FX 16 0.03 Lower share count 0.03 Higher tax rate (0.07) Restructuring / Productivity 0.09 Growth investments (0.04) FY 2014

  10. Slide 10: Outlook: 2014 Guidance Summary

    IDEX PROPRIETARY & CONFIDENTIAL 10 IDEX PROPRIETARY & CONFIDENTIAL Outlook: 2014 Guidance Summary Q1 2014 • EPS estimate range: $0.83 – $0.85 • Operating margin: ~ 20% FY 2014 • EPS estimate range: $3.33 – $3.43 – Organic revenue growth: ~ 3% – 5% – Operating margin: > 20% – Minimal FX impact • Othe

  11. Slide 11: Q&A

    IDEX PROPRIETARY & CONFIDENTIAL 11 IDEX PROPRIETARY & CONFIDENTIAL Q&A

Idex — Q4 2013 Earnings Presentation on 6ix